Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Rituximab × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 34 Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma, Follicular 24 Lymphoma, Mantle-Cell 19 Lymphoma, B-Cell, Marginal Zone 19 Lymphoma 19 Lymphoma, Non-Hodgkin 18 Lymphoma, B-Cell 12 Recurrence 11 Burkitt Lymphoma 10 Neoplasms 9 Waldenstrom Macroglobulinemia 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia 5 Leukemia, Hairy Cell 4 Hodgkin Disease 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Hematologic Diseases 2 Heart Failure 2 Dendritic Cell Sarcoma, Interdigitating 2 beta-Thalassemia 1 Thalassemia 1 Prostatic Neoplasms 1 Plasmablastic Lymphoma 1 Myelodysplastic Syndromes 1 Multi-centric Castleman's Disease 1 Macular dystrophy, corneal type 1 1

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡